MMRF MULTIPLE MYELOMA RESEARCH FOUNDATION Trademark

Trademark Overview

On Friday, August 8, 2014, a trademark application was filed for MMRF MULTIPLE MYELOMA RESEARCH FOUNDATION with the United States Patent and Trademark Office. The USPTO has given the MMRF MULTIPLE MYELOMA RESEARCH FOUNDATION trademark a serial number of 86361861. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, September 19, 2025. This trademark is owned by The Multiple Myeloma Research Foundation, Inc.. The MMRF MULTIPLE MYELOMA RESEARCH FOUNDATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research featuring the development of therapies and cures for multiple myeloma through scientific collaboration, accelerated research efforts, and the advancement of technologies; and providing on-line information about medical research relating to multiple myeloma via global a computer network
mmrf multiple myeloma research foundation

General Information

Serial Number86361861
Word MarkMMRF MULTIPLE MYELOMA RESEARCH FOUNDATION
Filing DateFriday, August 8, 2014
Status800 - REGISTERED AND RENEWED
Status DateFriday, September 19, 2025
Registration Number4742552
Registration DateTuesday, May 26, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 10, 2015

Trademark Statements

Description of MarkThe mark consists of the  letters "MM" and "RF" in a stylized box with solid lines, and the words "MULTIPLE MYELOMA RESEARCH FOUNDATION" to the right of the stylized box.
Amendment to a Registration/Renewal CertificateThe drawing is amended to appear as follows: PUBLISH NEW CUT; and in the statement, lines 15-17 is deleted and The mark consists of the letters "MM" and "RF" in a stylized box with solid lines, and the words "MULTIPLE MYELOMA RESEARCHFOUNDATION" to the right of the stylized box., is inserted.
Section 2(f) Limitation Statementas to "MULTIPLE MYELOMA"
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"RESEARCH FOUNDATION"
Goods and ServicesMedical and scientific research featuring the development of therapies and cures for multiple myeloma through scientific collaboration, accelerated research efforts, and the advancement of technologies; and providing on-line information about medical research relating to multiple myeloma via global a computer network

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 19, 2014
Primary Code042
First Use Anywhere DateWednesday, April 30, 2014
First Use In Commerce DateWednesday, April 30, 2014

Trademark Owner History

Party NameThe Multiple Myeloma Research Foundation, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorwalk, CT 06851
Party NameThe Multiple Myeloma Research Foundation, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorwalk, CT 06851
Party NameThe Multiple Myeloma Research Foundation, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorwalk, CT 06851

Trademark Events

Event DateEvent Description
Friday, September 19, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, September 16, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 2, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 1, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 3, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 19, 2025AMENDMENT UNDER SECTION 7 - PROCESSED
Tuesday, January 6, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, December 23, 2024TEAS SECTION 7 REQUEST RECEIVED
Tuesday, November 25, 2014NON-FINAL ACTION WRITTEN
Tuesday, January 27, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 3, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 16, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, September 19, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, August 12, 2014NEW APPLICATION ENTERED
Tuesday, August 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 10, 2015PUBLISHED FOR OPPOSITION
Tuesday, March 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, December 3, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 23, 2024TEAS SECTION 8 & 9 RECEIVED
Tuesday, January 6, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, January 6, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 25, 2014NON-FINAL ACTION E-MAILED
Tuesday, May 26, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, January 6, 2015EXAMINER'S AMENDMENT ENTERED
Wednesday, February 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 16, 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Friday, September 19, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, August 20, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, May 26, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, May 26, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 3, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 6, 2015ASSIGNED TO LIE
Friday, November 21, 2014ASSIGNED TO EXAMINER
Thursday, May 13, 2021TEAS SECTION 8 RECEIVED
Tuesday, November 25, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 3, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 14, 2025NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

Related Keywords

foundation research myeloma multiple mmrf medical scientific information line providing about relating